← Back to Search

Robotic Exoskeleton Rehabilitation for Cognitive Impairment

N/A

Recruiting

Research Sponsored by Kessler Foundation

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up approximately 12 weeks

Awards & highlights

Study Summary

This trial will study the effects of a robotic exoskeleton on mobility, learning, and memory in people with MS-related walking disability.

Who is the study for?

This trial is for individuals aged 18-75 with multiple sclerosis who have moderate to severe walking difficulties but can still walk using an exoskeleton. Participants should have cognitive challenges, be stable in their MS treatment for at least a month, and fit the physical requirements for the exoskeleton (height between 60 and 76 inches, weight under 220 lbs).Check my eligibility

What is being tested?

The study compares traditional gait therapy to rehabilitation using a wearable robotic exoskeleton called Ekso-GT. It aims to assess improvements in mobility, learning, memory, and walking abilities in people with Multiple Sclerosis.See study design

What are the potential side effects?

Potential side effects are not explicitly listed but may include discomfort or fatigue from wearing the device, skin irritation where it contacts the body, muscle soreness after use, or falls due to imbalance while adjusting to the exoskeleton.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ approximately 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~approximately 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Brain scans

Distance walked in a specific time duration

Neuropsychological measures of thinking

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Robotic Exoskeleton TherapyExperimental Treatment1 Intervention

Gait rehabilitation provided using a wearable robotic exoskeleton

Group II: Conventional Gait TherapyActive Control1 Intervention

Gait rehabilitation provided using traditional gait therapy under the supervision of a licensed PT

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Kessler Institute for RehabilitationIndustry Sponsor

22 Previous Clinical Trials

1,155 Total Patients Enrolled

Kessler FoundationLead Sponsor

173 Previous Clinical Trials

10,698 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings for participants in this clinical trial?

"Affirmative. Clinicaltrials.gov reports that this clinical study, which was initially made available on October 5th 2017, is currently recruiting participants. The trial requires 10 volunteers from a single medical centre to be enrolled in the program."

Answered by AI

Might I qualify to join this medical experiment?

"In order to qualify, potential participants must display duck gait and fall within the accepted age range of 18-75 years old. This trial is looking for around 10 enrollees in total."

Answered by AI

Are individuals beyond the age of 45 eligible to enroll in this research?

"The minimum age for enrollment in this clinical trial is 18 and the upper limit of eligibility is 75 years old."

Answered by AI

How many participants are being recruited for this experiment?

"Affirmative. The information available on clinicaltrials.gov shows that this trial is still looking for participants, having been first shared online on October 5th 2017 and most recently edited on May 23rd 2022. 10 patients are being requested from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS

2017. "Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04855825.

All > Diabetic Gastroparesis > Gastroparesis